SBI Securities’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368 Buy
82
+72
+720% +$285 ﹤0.01% 3139
2026
Q1
$37 Hold
10
﹤0.01% 3634
2025
Q4
$35 Hold
10
﹤0.01% 3649
2025
Q3
$21 Sell
10
-18
-64% -$38 ﹤0.01% 3902
2025
Q2
$63 Buy
28
+18
+180% +$25 ﹤0.01% 3669
2025
Q1
$14 Hold
10
﹤0.01% 3911
2024
Q4
$16 Buy
+10
New +$14 ﹤0.01% 3865

Other funds holding APYX

SBI Securities's APYX Position: Q2 2026 in Review

SBI Securities increased its Apyx Medical (APYX) stake by 720% in Q2 2026, buying an estimated $285 and bringing the position to 82 shares worth $368. The position accounts for ﹤0.01% of the portfolio, ranked #3139.

SBI Securities first reported a position in APYX in Q4 2024 and has held it in 7 quarters since. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • SBI Securities held 82 shares of Apyx Medical worth $368 as of Q2 2026.
  • SBI Securities bought 72 Apyx Medical shares in Q2 2026, an estimated $285.
  • Apyx Medical made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3139 holding.
  • SBI Securities first reported a position in Apyx Medical in Q4 2024 and has held it in 7 quarters since.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.